AML1-ETO hijacks a distal enhancer of NAT10 to reprogram glutathione metabolism and sustain leukemia stem cell stemness
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2608310123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Shuyi Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen University International Cancer Center, Department of Hematology and Oncology, Hematology Institution, Shenzhen University General Hospital,…. Hauptthemen laut MEDLINE: RUNX1 Translocation Partner 1 Protein, Core Binding Factor Alpha 2 Subunit, Oncogene Proteins, Fusion, Neoplastic Stem Cells. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Chromosomal translocations produce oncogenic fusion proteins such as AML1-ETO, which predominantly occupy gene promoters to induce transcriptional reprogramming in leukemia stem cells (LSCs), consequently driving the pathogenesis of t(8;21) acute myeloid leukemia (AML). However, whether AML1-ETO is recruited to additional regulatory DNA elements to orchestrate oncogenic gene expression programs has not been fully addressed. Here, we define AML1-ETO and H3K27ac CUT&Tag landscapes in primary t(8;21) AML CD34 + cells and t(8;21) AML cell lines, revealing AML1-ETO binding at a distal enhancer of the RNA N4-acetylcytidine (ac4C) writer N-acetyltransferase 10 (NAT10), thereby driving its transcriptional activation. Genetic ablation or pharmacological inhibition of NAT10 restricted the survival and self-renewal of LSCs in primary t(8;21) AML CD34 + cells, as well as in a retroviral AML1-ETO9a-driven t(8;21) AML mouse model, establishing NAT10 as a potential therapeutic vulnerability. Mechanistically, NAT10 is recruited to glutathione S-transferase omega 2 (GSTO2) mRNA to catalyze ac4C modification, thereby enhancing transcript stability and reprogramming glutathione metabolism, as demonstrated by ac4C profiling, RNA immunoprecipitation (RIP), and dCas13b-NAT10-based analyses. Silencing of GSTO2 in primary t(8;21) AML CD34 + cells decreased intracellular reduced glutathione (GSH) levels and compromised LSC survival and self-renewal, whereas GSTO2 overexpression or GSH supplementation largely rescued LSC maintenance following NAT10 loss. Collectively, these findings enrich and extend the understanding of AML1-ETO regulatory programs by linking distal enhancer activity to a NAT10–GSTO2 ac4C–GSH axis that integrates epigenomic, posttranscriptional, and metabolic reprogramming to sustain LSC stemness, highlighting this circuit as a potential therapeutic vulnerability in t(8;21) AML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen University International Cancer Center, Department of Hematology and Oncology, Hematology Institution, Shenzhen University General Hospital, International Science and Technology Cooperation: Carson Cancer Stem…
- Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen 518055, China.
ORCID-Profile: Yongwei Su, Jingfeng Zhou
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Li, S., He, S., Su, Y., Wang, L., Wang, Y., Xu, Y., Yu, L., & Zhou, J. (2026). AML1-ETO hijacks a distal enhancer of NAT10 to reprogram glutathione metabolism and sustain leukemia stem cell stemness. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2608310123
Vancouver
Li S, He S, Su Y, Wang L, Wang Y, Xu Y, et al. AML1-ETO hijacks a distal enhancer of NAT10 to reprogram glutathione metabolism and sustain leukemia stem cell stemness. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2608310123
BibTeX
@article{Li2026,
author = {Li, Shuyi and He, Shujiao and Su, Yongwei and Wang, Lei and Wang, Yiran and Xu, Yuanyuan and Yu, Li and Zhou, Jingfeng},
title = {AML1-ETO hijacks a distal enhancer of NAT10 to reprogram glutathione metabolism and sustain leukemia stem cell stemness},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2608310123}
}
EUVIMED